The Headaches in Claiming Antibody-based Inventions Broadly
LexBlog IP
OCTOBER 19, 2021
Recent Federal Circuit decisions call into question the value of patents broadly claiming inventions on antibodies and their function in treating debilitating diseases. Two are journal publications from the mid-1990s (and predating Teva’s patent filings, circa 2005). In Teva Pharmaceuticals Int’l GmbH v. ” Id.
Let's personalize your content